Investigators from Mass General Brigham have conducted a multi-ancestry, whole genome sequencing association study of Alzheimer's disease and found evidence for 16 new susceptibility genes, expanding ...

An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and ...

A union could address a host of issues, including cost-of-living raises, paid sick time, and a definition of “full-time work” ...

Mass General Brigham has announced a collaboration with Regent Surgical (“Regent”) to improve access and reduce costs for patients in New England by creating new MGB ambulatory surgery center ...

Regent Surgical will work to expedite Mass General Brigham's efforts to reduce wait times and improve the continuity of care.

In addition to Boston College Athletics, Mass General Brigham Sports Medicine provides clinical services to the Boston Bruins, New England Patriots and New England Revolution, as well as numerous ...

In addition, pivotal academic medical centers like Mass General Brigham in Boston and Yale New Haven Health are likely to be impacted on a major scale by President Donald Trump’s proposed cuts ...

Paris,France, Cambridge, USA,February 25, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for ...

Facing a quarter-billion-dollar budget gap over the next two years, Mass General Brigham announced earlier this month that ...

We recently published a list of 12 AI Updates Worth Taking a Look At. In this article, we are going to take a look at where ...

NFL fans are loving a graphic designer's re-design of the Cleveland Browns' logo. Check it out for yourself here.

Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a medical technology company dedicated to improving the lives of patients with blinding eye diseases, today announced it has secured a new patent ...